Alterations in Mitochondrial Oxidative Phosphorylation System: Relationship of Complex V and Cardiac Dysfunction in Human Heart Failure.
Isaac Giménez-EscamillaCarlota BenedictoLorena Pérez-CarrilloMarta Delgado-ArijaIrene González-TorrentRoger VilchezLuis Martínez DolzManuel PortolésEstefanía TarazónEsther Roselló-LletíPublished in: Antioxidants (Basel, Switzerland) (2024)
Heart failure (HF) is a disease related to bioenergetic mitochondrial abnormalities. However, the whole status of molecules involved in the oxidative phosphorylation system (OXPHOS) is unknown. Therefore, we analyzed the OXPHOS transcriptome of human cardiac tissue by RNA-seq analyses (mRNA n = 36; ncRNA n = 30) in HF patients (ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM)) and control subjects. We detected 28 altered genes in these patients, highlighting greater deregulation in ICM. Specifically, we found a general overexpression of complex V (ATP synthase) elements, among them, ATP5I (ICM, FC = 2.04; p < 0.01), ATP5MJ (ICM, FC = 1.33, p < 0.05), and ATP5IF1 (ICM, FC = 1.81; p < 0.001), which presented a significant correlation with established echocardiographic parameters of cardiac remodeling and ventricular function as follows: left ventricular end-systolic ( p < 0.01) and end-diastolic ( p < 0.01) diameters, and ejection fraction ( p < 0.05). We also detected an increase in ATP5IF1 protein levels (ICM, FC = 1.75; p < 0.01) and alterations in the microRNA expression levels of miR-208b-3p (ICM, FC = -1.44, p < 0.001), miR-483-3p (ICM, FC = 1.37, p < 0.01), regulators of ATP5I . Therefore, we observed the deregulation of the OXPHOS transcriptome in ICM patients, highlighting the overexpression of complex V and its relationship with cardiac remodeling and function.
Keyphrases
- left ventricular
- ejection fraction
- heart failure
- aortic stenosis
- rna seq
- end stage renal disease
- newly diagnosed
- peritoneal dialysis
- endothelial cells
- oxidative stress
- blood pressure
- transcription factor
- gene expression
- mitral valve
- cell proliferation
- atrial fibrillation
- poor prognosis
- acute coronary syndrome
- induced pluripotent stem cells
- patient reported outcomes
- protein kinase